Rights Contact Login For More Details
- Wiley
More About This Title Pharmacogenomics in Clinical Therapeutics
- English
English
- English
English
Amitava Dasgupta, Ph.D, DABCC, FACB, Professor of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX.
Loralie J. Langman, Ph.D, DABCC, FACB, Associate Professor of Laboratory Medicine, Mayo Clinic, Rochester, MN.
- English
English
Preface, ix
1 Pharmacogenomics Principles: Introduction to Personalized Medicine, 1
Parvaz Madadi, PhD and Gideon Koren, MD
2 Traditional Therapeutic Drug Monitoring and Pharmacogenomics: Are They Complementary? 15
Christine L.H. Snozek, PhD, Loralie J. Langman, PhD, and Amitava Dasgupta, Ph.D
3 Pharmacogenomics Aspect of Warfarin Therapy, 26
Matthew D. Krasowski, MD, PhD
4 Pharmacogenetics and Cancer Chemotherapy, 39
Christine L.H. Snozek
5 Pharmacogenomic Considerations in Anesthesia and Pain Management, 53
Christine M. Formea, PharmD and Wayne T. Nicholson, MD, PharmD
6 Pharmacogenomics of Immunosuppressants, 70
Nicolas Picard, PharmD, PhD and Pierre Marquet, MD, PhD
7 Pharmacogenomics of Cardiovascular Drugs, 98
Linnea M. Baudhuin, PhD
8 Pharmacogenomic Aspects of Antiretroviral Therapy, 127
Natella Y. Rakhmanina, MD, PhD and John N. van den Anker, MD, PhD
9 Pharmacogenetics of Psychoactive Drugs, 144
Jorge L. Sepulveda, MD, PhD
10 Pharmacogenomic Aspects of Adverse Drug–Drug Interactions, 176
Loralie J. Langman, PhD and Christine L.H. Snozek, PhD
11 Microarray Technology and Other Methods in Pharmacogenomics Testing, 185
Jorge L. Sepulveda, MD, PhD
12 Pharmacogenetic Testing in the Clinical Laboratory Environment, 201
Mark P. Borgman, PhD and Mark W. Linder, PhD
Index, 225
- English
English
“This book is unique in its focus on the application of pharmacogenomics in clinical therapeutics.” (Doody’s,
19 January 2013)